George Armah

TL;DR: In infants in developing countries in Asia, pentavalentrotavirus vaccine is safe and efficacious against severe rotavirus gastroenteritis, and the results support expanded WHO recommendations to promote its global use.

TL;DR: It is suggested that prioritizing vaccine introduction and interventions to reduce diarrhea-associated morbidity and mortality is necessary in the continued global reduction of rotavirus infection.

TL;DR: The ready acceptance of bednets, the high level of compliance in their use and the subsequent impact on all‐cause mortality in this study has important implications for programmes to control malaria in sub‐Saharan Africa.

TL;DR: In this article, the authors performed quantitative polymerase chain reaction for multiple enteropathogens on 878 acute watery diarrheal stools sampled from 14643 episodes captured by surveillance of children <5 years of age during 2013-2014 from 16 countries.

TL;DR: Results from the first 3 years following RV1 introduction suggest substantial reductions of pediatric diarrheal disease as a result of vaccination, consistent with the observed rotavirus decrease and with efficacy estimates from elsewhere in sub-Saharan Africa.